My watch list  


News PEGylation

  • Roche and Schering-Plough resolve peginterferon patent disputes

    Roche and Schering-Plough Corporation (NYSE: SGP) today announced that they have entered into a cross licensing agreement that settles all patent disputes relative to the two companies’ peginterferon products. Each party will also license to the other its patents applicable to peginterferon as more

White papers PEGylation

Publications PEGylation

All publications on pegylation


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE